Antibacterial macrocycles
View Patent ↗The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions comprising them, and their use in the treatment of diseases in humans or animals.
1. An antibacterial compound of the general formula (I)
in which
R 1 denotes halogen,
R 2 is hydrogen or halogen,
R 5 denotes hydrogen, C 1 -C 4 -alkyl, fluorine or chlorine,
R 6 denotes hydrogen, halogen or alkyl,
R 7 denotes alkyl or (cycloalkyl)alkyl,
R 8a denotes alkyl, alkylene, cycloalkyl or (cycloalkyl)alkyl,
where R 8a optionally can be substituted by 1, 2 or 3 substituents, which independently of one another are selected from the group consisting of hydroxyl, alkoxy, a radical —OR 8a-1 , carboxyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, heterocyclylaminosulfonyl, heteroarylaminosulfonyl, aminocarbonylamino, hydroxycarbonylamino, alkoxycarbonylamino, aminocarbonyloxy, in which R 8a-1 is a carbonyl-bonded amino acid radical,
or R 7 and R 8a , together with the carbon atom to which R 8a is bonded and the nitrogen atom to which R 7 is bonded, form a heterocyclyl ring, which optionally can be substituted by 1, 2 or 3 substituents, which independently of one another are selected from the group consisting of halogen, alkyl, trifluoromethyl, trifluoromethoxy, nitro, azido, amino, alkylamino, dialkylamino, hydroxyl, alkoxy, alkanoyloxy,
R 8a denotes hydrogen or alkyl,
R 9a denotes hydrogen, alkyl, hydroxyalkyl, carboxylalkyl or aminoalkyl,
R 9b denotes hydrogen or alkyl,
R 10a denotes hydrogen, alkyl or fluorine,
R 10b denotes hydrogen or fluorine,
R 11 denotes hydrogen or alkyl,
R 12 denotes alkyl, alkenyl, cycloalkyl, cycloalkenyl, (cycloalkyl)alkyl, (cycloalkenyl)alkyl, (cycloalkyl)alkenyl (cycloalkenyl)alkenyl,
where R 12 optionally can be substituted by 1, 2 or 3 substituents, which independently of one another are selected from the group consisting of halogen, hydroxyl, alkoxy, fluoroalkoxy, aryloxy, alkanoyloxy, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, heteroarylaminosulfonyl, heterocyclylaminosulfonyl, aminocarbonylamino, alkoxycarbonylamino,
or
R 6 and R 12 , together with the carbon atom to which they are bonded, form a cycloalkyl, which optionally can be substituted by 1 or 2 substituents, which independently of one another are selected from the group consisting of halogen, hydroxyl, alkoxy,
R 13 denotes hydrogen or alkyl,
A represents a heterocycle which optionally can be substituted by 1, 2 or 3 sub stituents, which independently of one another are selected from the group consisting of halogen, alkyl, trifluoromethyl, trifluoromethoxy, nitro, amino, alkylamino, dialkylamino, hydroxyl, alkoxy, alkanoyloxy, carboxyl, alkoxycarbonyl, azido, alkoxycarbonylamino,
represents a single or double bond,
or a pharmaceutically tolerable salt thereof.
2. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which
R 1 denotes halogen,
R 2 is hydrogen or halogen;
R 5 denotes hydrogen, methyl or fluorine,
R 6 denotes hydrogen or C 1 -C 4 -alkyl,
R 7 denotes alkyl,
R 8a denotes alkyl, alkylene, cycloalkyl or (cycloalkyl)alkyl,
where R 8a optionally can be substituted by 1 or 2 substituents, which independently of one another are selected from the group consisting of hydroxyl, alkoxy, a radical —OR 8a-1 , alkoxycarbonyl, amino, alkylamino, dialkylamino, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonylamino,
in which R 8a is a carbonyl-bonded amino acid radical,
or R 7 and R 8a , together with the carbon atom to which R 8a is bonded and the nitrogen atom to which R 7 bonded, form a heterocyclyl ring, which optionally can be substituted by 1 or 2 substituents, which independently of one another are selected from the group consisting of halogen, alkyl, amino, alkylamino, dialkylamino, hydroxyl, alkoxy, alkanoyloxy,
R 8b denotes hydrogen,
R 9a denotes hydrogen, methyl or hydroxymethyl,
R 9b denotes hydrogen,
R 10a denotes hydrogen,
R 10b denotes hydrogen,
R 11 denotes hydrogen,
R 12 denotes alkyl, alkenyl, (cycloalkyl)alkyl, (cycloalkenyl)alkyl, (cycloalkyl)alkenyl (cycloalkenyl)alkenyl,
where R 12 optionally can be substituted by 1 or 2 substituents, which independently of one another are selected from the group consisting of halogen, hydroxyl, alkoxy,
or
R 6 and R 12 , together with the carbon atom to which they are bonded, form a cycloalkyl, which optionally can be substituted by 1 or 2 substituents, which independently of one another are selected from the group consisting of halogen, hydroxyl, alkoxy,
R 13 denotes hydrogen,
A represents a heterocycle which optionally can be substituted by 1 or 2 substituents, which independently of one another are selected from the group consisting of fluorine, alkyl, trifluoromethyl, alkoxycarbonylamino,
represents a single or double bond,
or a pharmaceutically tolerable salt thereof.
3. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which
R 1 denotes fluorine,
R 2 denotes hydrogen or fluorine,
R 5 denotes hydrogen or fluorine,
R 6 denotes hydrogen,
R 7 denotes methyl,
R 8a denotes C 1 -C 4 -alkyl,
where R 8a optionally can be substituted by 1 substituent selected from the group consisting of hydroxyl and a radical —OR 8a-1 ,
in which R 8a-1 is an aminomethylcarbonyl radical, or
R 7 and R 8a , together with the carbon atom to which R 8a is bonded and the nitrogen atom to which R 7 is bonded, form a 5- to 6-membered nitrogen heterocyclyl ring, which can contain up to 2 nitrogen atoms and which optionally can be substituted by 1 substituent selected from the group consisting of alkyl, amino, alkylamino, dialkylamino, hydroxyl,
R 8b denotes hydrogen,
R 9a denotes hydrogen, alkyl or hydroxymethyl,
R 9b denotes hydrogen,
R 10a denotes hydrogen,
R 10b denotes hydrogen,
R 11 denotes hydrogen,
R 12 denotes alkyl, alkenyl, cycloalkyl, cycloalkenyl, (cycloalkyl)alkyl, (cycloalkenyl)alkyl, (cycloalkyl)alkenyl (cycloalkenyl)alkenyl,
where R 12 optionally can be monosubstituted by hydroxyl,
or
R 6 and R 12 , together with the carbon atom to which they are bonded, form a 5- to 6-membered cycloalkyl, which optionally can be monosubstituted by hydroxyl,
R 13 denotes hydrogen,
A represents a 5-membered heterocycle which contains 1 nitrogen atom and which optionally can be monosubstituted by a substituent selected from the group consisting of fluorine, alkyl,
represents a single or double bond,
or a pharmaceutically tolerable salt thereof.
4. An antibacterial compound as claimed in claim 1 , which has the general formula (II):
in which
A,
and R 1 , R 2 and R 5 to R 12 are as defined in claim 1 .
5. An antibacterial compound of the general fonnula (I) as claimed in claim 1 , in which R 5 denotes hydrogen.
6. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which R 6 denotes hydrogen.
7. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which R 7 denotes methyl.
8. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which R 8a denotes methyl hydroxymethyl or —OR 8a-1 , in which R 8a-1 denotes a carbonylbonded amino acid radical and R 8b denotes hydrogen.
9. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which in which R 9a denotes alkyl, and R 9b denotes hydrogen.
10. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which R 10a and R 10b denote hydrogen.
11. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which R 11 denotes hydrogen.
12. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which R 12 is selected from the following group:
13. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which R 13 denotes hydrogen.
14. An antibacterial compound of the general formula (I) as claimed in claim 1 , in which A is a 5-membered heterocycle which contains 1 nitrogen atom and which optionally can be monosubstituted by a substituent selected from the group consisting of fluorine and alkyl.
15. A process for the preparation of the compounds of the general formula (I) as claimed in claim 1 , in which compounds of the general formula (V)
in which
R 1 , R 2 , R 7 to R 11 , R 13 and A have the meaning indicated in claim 1 ,
are reacted with compounds of the general formula (XXV)
in which
R 5 , R 6 , R 12 and
have the meaning indicated in claim 1 ,
where these optionally can be present in activated form.
16. A medicament comprising an antibacterial compound of the general formula (I) as claimed in claim 1 and excipients.
17. A compound of the general formula (I)
in which
R 1 denotes halogen, alkyl, trifluoromethyl, trifluoromethoxy, nitro, amino, alkylamino, dialkylamino or alkylcarbonylamino,
R 2 denotes hydrogen, halogen, alkyl, nitro, amino, alkylamino, dialkylamino, or alkylcarbonylamino,
R 3 denotes hydrogen, halogen, alkyl, nitro, amino, alkylamino, dialkylamino, or alkylcarbonylamino,
R 4 denotes hydrogen, halogen, alkyl, nitro, amino, alkylamino, dialkylamino, or alkylcarbonylamino,
R 5 denotes hydrogen, C 1 -C 4 -alkyl, fluorine or chlorine,
R 6 denotes hydrogen, halogen or alkyl,
R 7 and R 8a , together with the carbon atom to which R 8a is bonded and the nitrogen atom to which R 7 is bonded, form a heterocyclyl ring, which optionally can be substituted by 1 or 2 substituents, which independently of one another are selected from the group consisting of halogen, alkyl and amino,
R 8b denotes hydrogen or alkyl,
R 9a denotes hydrogen, alkyl, hydroxyalkyl, carboxylalkyl or aminoalkyl,
R 9b denotes hydrogen or alkyl,
R 10a denotes hydrogen, alkyl or fluorine,
R 10b denotes hydrogen or fluorine,
R 11 denotes hydrogen or alkyl,
R 12 denotes alkyl, alkenyl, cycloalkyl, cycloalkenyl, (cycloalkyl)alkyl, (cycloalkenyl)alkyl, (cycloalkyl)alkenyl (cycloalkenyl)alkenyl,
where R 12 optionally can be substituted by 1, 2 or 3 substituents, which independently of one another are selected from the group consisting of halogen, hydroxyl, alkoxy, fluoroalkoxy, aryloxy, alkanoyloxy, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, heteroarylaminosulfonyl, heterocyclylaminosulfonyl, aminocarbonylamino, alkoxycarbonylamino,
or
R 6 and R 12 , together with the carbon atom to which they are bonded, form a cycloalkyl, which optionally can be substituted by 1 or 2 substituents, which independently of one another are selected from the group consisting of halogen, hydroxyl, alkoxy,
R 13 denotes hydrogen or alkyl,
A represents a heterocycle which optionally can be substituted by 1, 2 or 3 substituents, which independently of one another are selected from the group consisting of halogen, alkyl, tnfluoromethyl, trifluoromethoxy, nitro, amino, alkylamino, dialkylamino, hydroxyl, alkoxy, alkanoyloxy, carboxyl, alkoxycarbonyl, azido, alkoxycarbonylamino,
repesents a single or double bond,
or a pharmaceutically tolerable salt thereof.
18. A compound of the general formula (I)
in which
R 1 denotes halogen, alkyl, trifluoromethyl, trifluoromethoxy, nitro, amino, alkylamino, dialkylamino or alkylcarbonylamino,
R 2 denotes hydrogen, halogen, alkyl, nitro, amino, alkylamino, dialkylamino, or alkylcarbonylamino,
R 3 denotes hydrogen, halogen, alkyl, nitro, amino, alkylamino, dialkylamino, or alkylcarbonylamino,
R 4 denotes hydrogen, halogen, alkyl, nitro, amino, alkylamino, dialkylamino, or alkylcarbonylamino,
R 5 denotes hydrogen, C 1 -C 4 -alkyl, fluorine or chlorine,
R 6 denotes hydrogen, halogen or alkyl,
R 7 denotes alkyl or (cycloalkyl)alkyl,
R 8a denotes alkyl, alkylene, cycloalkyl or (cycloalkyl)alkyl,
where R 8a optionally can be substituted by 1, 2 or 3 substituents, which independently of one another are selected from the group consisting of hydroxyl, alkoxy, a radical —OR 8a-1 , carboxyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, aminosulfonyl, alkylaminosulfonyl, dialkylaminosulfonyl, arylaminosulfonyl, heterocyclylaminosulfonyl, heteroarylaminosulfonyl, aminocarbonylamino, hydroxycarbonylamino, alkoxycarbonylamino, aminocarbonyloxy, in which R 8a-1 is a carbonyl-bonded amino acid radical,
or R 7 and R 8a , together with the carbon atom to which R 8a is bonded and the nitrogen atom to which R 7 is bonded, form a heterocyclyl ring, which optionally can be substituted by 1, 2 or 3 substituents, which independently of one another are selected from the group consisting of halogen, alkyl, trifluoromethyl, trifluoromethoxy, nitro, azido, amino, alkylamino, dialkylamino, hydroxyl, alkoxy, alkanoyloxy,
R 8b denotes hydrogen or alkyl,
R 9a denotes hydrogen, alkyl, hydroxyalkyl, carboxylalkyl or aminoalkyl,
R 9b denotes hydrogen or alkyl,
R 10a denotes hydrogen, alkyl or fluorine,
R 10b denotes hydrogen or fluorine,
R 11 denotes hydrogen or alkyl,
R 12 denotes C 3 -C 8 -alkyl,
R 13 denotes hydrogen or alkyl,
A represents a heterocycle which optionally can be substituted by 1, 2 or 3 substituents, which independently of one another are selected from the group consisting of halogen, alkyl, trifluoromethyl, trifluoromethoxy, nitro, amino, alkylamino, dialkylamino, hydroxyl, alkoxy, alkanoyloxy, carboxyl, alkoxycarbonyl, azido, alkoxycarbonylamino,
represents a single or double bond,
or a pharmaceutically tolerable salt thereof.